Get my own profile
Public access
View all1 article
0 articles
available
not available
Based on funding mandates
Co-authors
- Gavin K. ReynoldsSenior Principal Scientist, AstraZenecaVerified email at astrazeneca.com
- Michael AdamsUniversity of BirminghamVerified email at bham.ac.uk
- Jonathan SevilleProfessor of Formulation Engineering, University of BirminghamVerified email at bham.ac.uk
- Agba D SalmanUniversity of SheffieldVerified email at sheffield.ac.uk
- CY WuProfessor of Chemical EngineeringVerified email at surrey.ac.uk
- Mike HounslowEmeritus Professor, Faculty of Engineering, University of SheffieldVerified email at sheffield.ac.uk
- Johan TryggProfessor of Chemometrics, Umeå University, SwedenVerified email at umu.se
- Pirjo TajarobiPrincipal Scientist, AstraZenecaVerified email at astrazeneca.com
- Arno KwadeBraunschweigVerified email at tu-bs.de
- Jan Henrik FinkeDivision Head in Pharma and Bioparticle Technology, Institute for Particle Technology, TUVerified email at tu-braunschweig.de
- Thomas LeadbeaterDepartment of Physics, University of Cape TownVerified email at uct.ac.za
- Martin SnowdenIndependent ScientistVerified email at gre.ac.uk
- Professor JC MitchellUniversity of GreenwichVerified email at gre.ac.uk
- James AndrewsThe University of BirminghamVerified email at bham.ac.uk
- Wu Ching-SenAssistant Professor, National Ilan UniversityVerified email at ntu.edu.tw